New York, NY – Researchers from the Icahn School of Medicine at Mount Sinai have found that most COVID-19 patients have persistent antibodies to the SARS-CoV-2 virus at levels that are correlated with neutralization of the virus more than…
Program, an official partner of the New York State Excelsior Pass program, offers fast and accurate testing
Mount Sinai Health System announced today that Kantaro Biosciences, LLC, a joint venture with RenalytixAI, has been named to Fast Company’s prestigious annual list of the “World’s Most Innovative Companies” for 2021 and ranked first in the Joint Ventures category.
The Dubin Breast Center of The Tisch Cancer Institute at the Mount Sinai Health System celebrated its 10th anniversary during its annual gala on Monday, December 7, 2020. The evening honored Eva Andersson-Dubin, MD, founder of the Center and a Mount Sinai trustee, and Elisa Port, MD, FACS, the Center’s Director and Chief of Breast Surgery for the Mount Sinai Health System, and raised more than $2.3 million to benefit the Dubin Breast Center. The center is part of The Tisch Cancer Institute, a National Cancer Institute-designated cancer center.
Growing numbers of COVID-19 cases and deaths are troubling; facemasks can slow the trend
Results may lead to closer monitoring of heart failure patients in hospital and at home
The Tisch Cancer Institute at Mount Sinai (TCI) has been awarded $13 million as part of the renewal of its National Cancer Institute Cancer Center Designation, a prestigious distinction that is based on scientific excellence, robust clinical research, and beneficial community impact. The National Cancer Institute rated TCI’s application as “outstanding.”
New generation implant has improved safety and performance features for those with atrial fibrillation
Mount Sinai Health System and Cross County Cardiology announced a new cooperative partnership today that will include five cardiology practices located throughout Bergen and Hudson counties in New Jersey. Cross County Cardiology-Mount Sinai Doctors will work to enhance clinical care for patients with cardiovascular disease bringing the most advanced techniques within the field of cardiology and vascular care to the region.
Grant Will Enable Development of AI Tools to Enhance Care and Evidence-based Medicine for Treating COVID-19 Patients
Center to provide post-multidisciplinary care and psychosocial resources for patients recovering from pandemic disease
COVID-19 Registry and clinical trials component will define new standards of care for patients
A New Nest Camera Console Enhances Safety of Patients and Staff; Reduces PPE Demands
Scientists at the Icahn School of Medicine at Mount Sinai have discovered a new role for the brain chemical dopamine that is independent of classic neurotransmission. The new role appears to be critical to changes in gene expression related to chronic exposure to, or abuse of, cocaine, according to a study published Friday, April 10, in the journal Science.
Mount Sinai research highlights the need for more hearing checks among groups at high risk for falls
Appointment Enhances Efforts by the Institute to Improve Health of Communities Locally and Internationally
In the future, robots could take blood samples, benefiting patients and healthcare workers alike. A Rutgers-led team has created a blood-sampling robot that performed as well or better than people, according to the first human clinical trial of an automated blood drawing and testing device.
Dolores Hambardzumyan, PhD, MBA, has been appointed Senior Faculty in the Department of Neurosurgery and a member of The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.
A minimally invasive procedure to treat a common foot and ankle disorder can reduce pain, recovery time, and postsurgery complications while improving functional outcomes.
Atlanta Falcons and Atlanta United owner Arthur Blank and Nina Bhardwaj, MD, PhD, will be honored for their contributions to prostate cancer research.